Free Trial

Stock Analyst Initiations

Track the latest stock analyst initiations, newly initiated coverage, and first-time analyst ratings in this regularly updated list of analyst recommendations. This page compiles new initiations, including initial stock ratings, buy/hold/sell recommendations, and price targets, so you can monitor all recent coverage openings across the market.

CompanyActionBrokerageAnalystCurrent PricePrice TargetRatingDetails
Ascentage Pharma Group International - Unsponsored ADR stock logo
AAPG
Ascentage Pharma Group International
Initiated by$17.45
+2.2%
$45.00Buy
ADMA Biologics Inc stock logo
ADMA
ADMA Biologics
Initiated by $8.48
+4.4%
$21.00Strong-BuyOutperform
AnaptysBio, Inc. stock logo
ANAB
AnaptysBio
Initiated by$52.20
+1.1%
$95.00Buy
Bel Fuse Inc. stock logo
BELFB
Bel Fuse
Initiated by$276.95
+0.3%
$370.00Overweight
Barnes & Noble Education, Inc stock logo
BNED
Barnes & Noble Education
Initiated by$10.84
+2.0%
$17.00Outperform
BXDC
Blackstone Digital Infrastructure Trust
Initiated by$21.81
-2.2%
$23.00Equal Weight
Elicio Therapeutics, Inc. stock logo
ELTX
Elicio Therapeutics
Initiated by$14.30
+0.7%
$27.00Buy
Emerson Electric Co. stock logo
EMR
Emerson Electric
Initiated by$137.16
-3.7%
$175.00Outperform
Equity Bancshares, Inc. stock logo
EQBK
Equity Bancshares
Initiated by $47.89
+0.7%
$51.00Market Perform
Honeywell International Inc. stock logo
HON
Honeywell International
Initiated by$206.08
-4.5%
$233.00Market Perform
SpaceX is offering you shares. Don't take them. (Ad)

SpaceX is reserving 30% of its IPO shares for retail investors through Robinhood, Fidelity, and Schwab. But at a $1.75 trillion valuation and 266 times earnings, early institutional holders may be looking for someone to sell to. Dylan Jovine has identified a small company in Musk's supply chain that builds the power infrastructure behind Colossus - still trading at a fraction of its potential value. No IPO allocation required.tc pixel

Get the backdoor ticker free before the SpaceX IPO launches
Hyliion Holdings Corp. stock logo
HYLN
Hyliion
Initiated by$6.94
+9.4%
$9.00Buy
Inhibikase Therapeutics, Inc. stock logo
IKT
Inhibikase Therapeutics
Initiated by $1.67
-0.3%
$5.00Outperform
indie Semiconductor, Inc. stock logo
INDI
indie Semiconductor
Initiated by$3.96
-1.6%
$4.00Hold
NWPX Infrastructure, Inc. stock logo
NWPX
NWPX Infrastructure
Initiated by$122.31
-0.8%
$130.00Neutral
Power Integrations, Inc. stock logo
POWI
Power Integrations
Initiated by$74.38
-0.4%
$90.00Buy
Stora Enso Oyj stock logo
SEOAY
Stora Enso Oyj
Initiated by $10.91
-5.9%
Neutral
Solid Power, Inc. stock logo
SLDP
Solid Power
Initiated by $2.78
-0.9%
$6.75Buy
TransAlta Corporation stock logo
TAC
TransAlta
Initiated by$12.41
-0.4%
Outperform
TransAlta Corporation stock logo
TAC
TransAlta
Initiated by $12.41
-0.4%
Buy

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 04:18 PM ET.

Frequently Asked Questions

Analyst ratings are the "buy" and "sell" labels, plus price targets, that investment researchers attach to specific securities. These ratings are based on financial data, earnings reports  and conversations with company executives.

Analyst ratings provide plenty of helpful information, but you shouldn't use an analyst's "buy" rating as the sole reason you purchase a security. Analysts aren't immune to conflicts of interest or outside parties' influence, so ensure you always understand why a stock was labeled a "buy" or "sell."

Ratings give investors the analyst's overall opinion about a particular stock and price targets based on the company's valuation and prospects. Analysts often attend conference calls, ask questions and provide in-depth information about companies that are difficult to acquire elsewhere.